الفهرس | Only 14 pages are availabe for public view |
Abstract Aim: The objective of the current study was to evaluate the survival rate following TheraCal PT pulpotomy compared to MTA pulpotomy in pediatric patients with primary molars indicated for vital pulpotomy. Methodology: Twenty patients were recruited for the current pilot randomized clinical study. Patients were divided into two groups: group I for TheraCal PT (n=10) and group II for MTA (n=10). All patients were subjected to baseline, 3, and 6-month follow-ups. The primary outcome included evaluating the clinical survival rate regarding spontaneous pain and the formation of swelling. The secondary outcomes utilized the radiographic assessment regarding widening in periodontal membrane space, periapical radiolucency, furcation involvement, external/internal root restoration, and Time elapsed from the beginning of hemostasis till the final restoration placement was recorded. Results: After six months, both materials exhibited a 100% survival rate for the clinical parameters tested (spontaneous pain and swelling). The clinical assessment showed no statistically significant difference between MTA and TheraCal PT groups. Radiographic assessments have shown a 90% success rate for the MTA group and a 40% success rate for the Theracal PT group. The overall inter-observer agreement (Kappa score) for clinical and radiographic assessments has shown near-perfect agreement between observers (κ = 0.97). Conclusion: MTA and Theracal PT medications had an excellent clinical success rate of 100% during the follow-up period; moreover, MTA revealed more radiographic success rate than Theracal PT (90% and 40% respectively). Keywords: MTA, Primary molars, TheraCal PT pulpotomy, Vital pulp treatment. |